(Health-NewsWire.Net, April 16, 2022 ) Non-invasive Prenatal Testing Market 2022
Non-invasive Prenatal Testing (NIPT) Market is expected to be worth US$ 1,447.2 Mn by the year 2016-2024, at a CAGR of 10.2% between 2016-2024. Digital health is into occupation of a noteworthy position in our lives, thereby rendering it a significant tool in the medical device trends going forward. This would be the overall outlook of the healthcare vertical in the forecast period.
Click Here to Get Free Sample Copy of This Report@https://www.persistencemarketresearch.com/samples/11218
Advancing the prenatal care services provided across the globe has become an uphill battle for medical practitioners and drugmakers. Fortunately, this struggle is being eased by active participation of parents from all around the world in protecting the health of their soon-to-be-born babies through prenatal disease detection methods.
Noninvasive prenatal testing (NIPT) procedures are, hence, being rapidly adopted, which is prompting healthcare service providers to increase their focus on such prenatal diagnosis & screening services. Persistence Market Research recently published its study on the global market for noninvasive prenatal testing, which projects the market to bring in US$ 1,447.2 Mn revenues by the end of 2024.
At present, Persistence Market Research values the global noninvasive prenatal testing market at just over US$ 665 Mn, and expects the market to incur revenue growth at an impressive 10.2% CAGR. According to the report, titled “Noninvasive Prenatal Testing Market: Global Industry Analysis and Forecast, 2016-2024,” the global demand for noninvasive prenatal testing will keep surging on the account of rising innovations in prenatal screening products.
Growing presence of ADHD disorders among young adults is also triggering the adoption of noninvasive prenatal testing. Moreover, the demand for noninvasive prenatal tests is expected to grow as a majority of young adults are being introduced to generic medications. Nevertheless, stringent usage regulations and records of drug abuse are expected to curb the growing adoption of noninvasive prenatal testing to some extent.
Request For Customization@https://www.persistencemarketresearch.com/request-customization/11218
Some of the prominent companies providing noninvasive prenatal testing in the world are identified as, Ariosa Diagnostics, Inc., BGI Diagnosis Co. Ltd., Berry Genomics Corporation, Illumina, Inc., LifeCodexx AG, Natera, Inc., Sequenom, Inc., Quest Diagnostic Incorporated, and Laboratory Corporation of America Holdings. A majority of these companies are based in the US, which is why North America is projected to procure an average 60% of global NIPT revenues through 2024. The demand for noninvasive prenatal testing will also be more in Asia-Pacific, and the region’s NIPT market is looking at an opportune US$ 18 Mn increment in 2017 over 2016. Europe’s noninvasive prenatal testing revenues, on the other hand, will also grow aggressively – registering a 10% CAGR during the forecast period.
The report reveals that a considerable share of global NIPT revenues will be derived from higher preference to panel 1 test type. Adoption of panel 1 noninvasive prenatal testing has been projected to rise, bringing in over US$ 850 Mn revenues by the end of 2024. On the hand, global revenues from panel 2 tests are anticipated to soar at a healthy CAGR of 9.7%. Correspondingly, hospitals will remain the largest end-users of noninvasive prenatal testing throughout the forecast period. In the due course of this period, hospitals will not only account for half of global NIPT market value, but will also exhibit revenue growth at highest CAGR of 11.1%.
Click Here to Get Full Report@https://www.persistencemarketresearch.com/checkout/11218
Global Noninvasive Prenatal Testing Market – Key Trends
Impact of changing lifestyles: Urban livelihood and rising per capita income of individuals has propelled the occurrence of high-risk pregnancies. Unhealthy habits such as smoking, drinking and working around the clock has given rise to complications in maternal and neonatal outcomes.
Advanced maternal age: Occurrence of women in their late 30s giving birth for the first time has increased. To avoid birth defects and consider the advanced age of mother, doctors are also promoting the adoption of noninvasive prenatal screening.
Classification as “LDT”: More healthcare & pharmaceutical companies are entering the global NIPT market as these tests have been tagged as “lab-developed tests” by the FDA.
You Can Also Read-
Animal Parasiticide Market-
The global animal parasiticides market has registered a value of US$ 6,976.2 Mn in 2015 and is anticipated to reach a value of US$ 13,064.7 Mn by 2026 with the projected CAGR of 5.9% during the forecast period (2015–2026).
Peripherally Inserted Central Catheters Market -
Global peripherally inserted central catheters market value is expected to increase to US$ 1058.6 Mn by the end of 2024.
Hemoglobinopathy Market -
global hemoglobinopathy market is projected to register a CAGR of 8.3% during the forecast period in terms of value and is expected to reach a market valuation of US$ 788.2 Mn by the end of 2024.
Surgical Lamps Market -
global surgical lamps market was valued at USD 5,54,938.8 thousand in 2014 and is expected to grow at a CAGR of 4.6% from 2014 to 2020, to reach USD 7,28,915.2 thousand by 2020.
PersistenceMarketResearch is an esteemed company with a reputation of serving clients across domains of information technology (IT), healthcare, and chemicals. Our analysts undertake painstaking primary and secondary research to provide a seamless report with a 360 degree perspective. Data is compared against rep/uted organizations, trustworthy databases, and international surveys for producing impeccable reports backed with graphical and statistical information.
Persistence Market Research
305 Broadway,7th Floor New York City, NY 10007 United States
Call +1 800-961-0353
Persistence Market Research